120 likes | 158 Views
<br>Read here the latest updates on the COLONOSCOPY BOWEL PREPARATION DRUGS MARKET ANALYSIS published by CMI team.<br>
E N D
Coherent Marketing Insights https://www.coherentmarketinsights.com/ Market Research & Business Consulting Services Covid-19 Impact Tracker
COLONOSCOPY BOWEL PREPARATION DRUGS MARKET ANALYSIS Colonoscopy Bowel Preparation Drugs Market, by Drug Type (Isosmotic Agents, Hyposmotic Agents, Hyperosmotic Agents, and Combination Agents), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Colonoscopy Bowel Preparation Drugs Market – Market Insights Colonoscopy is an important screening test for detecting colorectal cancer. Colonoscopy is dependent on pre-procedure called as colonoscopy bowel preparation where the cleansing of colon is done in the patients undergoing colonoscopy. The global colonoscopy bowel preparation drugs market was valued at US$ 1,574.9 million in 2018 and is expected to exhibit a CAGR of 4.9% over the forecast period (2019-2027).
Figure 1. Global Colonoscopy Bowel Preparation Drugs Market Value (US$ Mn), by Region, 2018
The rising research and development activities is expected to boost growth of the colonoscopy bowel preparation drugs market Colonoscopy bowel preparation drugs market is expected to witness significant growth, owing to rising research and development activities for the development of innovative bowel preparation drugs, in order to offer better products in the market. For instance, in December 2019, ColonaryConcepts LLC, a biotechnological company engaged in the development of colon preparation products, announced the Phase III clinical trial of its Edible Colonoscopy (EC) preparation used for bowel cleansing. Colonoscopy bowel preparation drugs market is expected to witness significant growth, owing to increasing adoption of agreement and collaboration strategies by the market players. For instance, in January 2019, Norgine B.V. and KOREA PHARMA CO., LTD., a premier pharmaceutical manufacturer in Korea, entered into an exclusive license and distribution agreement in the Republic of Korea, by which Korea Pharma will commercialize and distribute Norgine’s product, PLENVU, in Korea.
Figure 2. Global Colonoscopy Bowel Preparation Drugs Market Share (%), by Product Type, 2019 and 2027
Colonoscopy Bowel Preparation Drugs Market - Regional Analysis North America held a dominant position in the global colonoscopy bowel preparation drugs market in 2018, owing to rising incidence of colorectal cancer in the region. For instance, according to the Global Cancer statistics (GLOBOCAN) published in January 2020, in the U.S., around 147,950 new cases of large bowel cancer are diagnosed annually, of which around 104,610 cases are of colon cancer and the remaining are colorectal cancer. According to the same source, around 53,200 Americans die every year due to colorectal cancer, which accounts for around 8% of all cancer deaths occurring, globally. Moreover, Europe is expected to witness significant growth in the colonoscopy bowel preparation drugs market during the forecast period, owing to rising adoption of inorganic growth strategies such as collaborations and agreements by key players, in order to expand their geographical presence and product portfolio. For instance, in October 2017, Norgine B.V. received marketing authorization from the UK Medicines and Healthcare Regulatory Agency (MHRA) for PLENVU (NER1006) for bowel cleansing in adults prior to colonoscopy.
Key Players Major players operating in the global colonoscopy bowel preparation drugs market include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.
Request Sample Report Request Customization Download PDF Brochure Talk to Analyst Referance: https://www.coherentmarketinsights.com/market-insight/colonoscopy-bowel-preparation-drugs-market-3641
About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. What We Provide:Customized Market Research AnalysisIndustry Analysis ServicesBusiness Consulting ServicesLong Term Engagement ModelCountry Specific Analysis
Contact Us Mr. Shah Coherent Market Insights Pvt. LTD.Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S.Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You Kindly Follow CMI Social Media Profiles for the latest Company Updates. Facebook Linkedin Twitter https://www.coherentmarketinsights.com/